< Terug naar vorige pagina

Publicatie

Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections Revised Ms SBMB 2020_166

Tijdschriftbijdrage - Tijdschriftartikel

Coronavirus infection is a serious health problem awaiting an effective vaccine and/or antiviral treatment. The major complication of coronavirus disease 2019 (COVID-19), the Acute Respiratory Distress syndrome (ARDS), is due to a variety of mechanisms including cytokine storm, dysregulation of the renin-angiotensin system, neutrophil activation and increased (micro)coagulation. Based on many preclinical studies and observational data in humans, ARDS may be aggravated by vitamin D deficiency and tapered down by activation of the vitamin D receptor. Several randomized clinical trials using either oral vitamin D or oral Calcifediol (25OHD) are ongoing. Based on a pilot study, oral calcifediol may be the most promising approach. These studies are expected to provide guidelines within a few months.
Tijdschrift: Journal of Steroid Biochemistry and Molecular Biology
ISSN: 0960-0760
Volume: 202
Aantal pagina's: 8
Jaar van publicatie:2020
Trefwoorden:Biochemie & -fysica en Moleculaire biologie, Endocrinologie en metabole geneeskunde